PRIMARY SCLEROSING CHOLANGITIS (PSC)
Clinical trials for PRIMARY SCLEROSING CHOLANGITIS (PSC) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SCLEROSING CHOLANGITIS (PSC) trials appear
Sign up with your email to follow new studies for PRIMARY SCLEROSING CHOLANGITIS (PSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New biodegradable stents offer hope for PSC patients
Disease control Recruiting nowThis study tests whether biodegradable stents can safely open narrowed bile ducts in 20 people with primary sclerosing cholangitis (PSC). The stents are placed during an endoscopic procedure and dissolve over time, aiming to improve symptoms like itching and fatigue and prevent t…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Phase: NA • Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug LB-P8 aims to tame rare liver disease PSC
Disease control Recruiting nowThis study tests a new drug, LB-P8, in 87 adults with primary sclerosing cholangitis (PSC), a rare liver disease. The goal is to see if LB-P8 is safe and can lower levels of alkaline phosphatase (ALP), a marker of liver damage. Participants will receive either LB-P8 or a placebo,…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Phase: PHASE2 • Sponsor: LISCure Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC